Cargando…
Antitumor Mechanism of Hydroxycamptothecin via the Metabolic Perturbation of Ribonucleotide and Deoxyribonucleotide in Human Colorectal Carcinoma Cells
Hydroxycamptothecin (SN38) is a natural plant extract isolated from Camptotheca acuminate. It has a broad spectrum of anticancer activity through inhibition of DNA topoisomerase I, which could affect DNA synthesis and lead to DNA damage. Thus, the action of SN38 against cancers could inevitably affe...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398164/ https://www.ncbi.nlm.nih.gov/pubmed/34443490 http://dx.doi.org/10.3390/molecules26164902 |
_version_ | 1783744772452646912 |
---|---|
author | Li, Yan Luo, Wendi Zhang, Huixia Wang, Caiyun Yu, Caiyuan Jiang, Zhihong Zhang, Wei |
author_facet | Li, Yan Luo, Wendi Zhang, Huixia Wang, Caiyun Yu, Caiyuan Jiang, Zhihong Zhang, Wei |
author_sort | Li, Yan |
collection | PubMed |
description | Hydroxycamptothecin (SN38) is a natural plant extract isolated from Camptotheca acuminate. It has a broad spectrum of anticancer activity through inhibition of DNA topoisomerase I, which could affect DNA synthesis and lead to DNA damage. Thus, the action of SN38 against cancers could inevitably affect endogenous levels of ribonucleotide (RNs) and deoxyribonucleotide (dRNs) that play critical roles in many biological processes, especially in DNA synthesis and repair. However, the exact impact of SN38 on RNs and dRNs is yet to be fully elucidated. In this study, we evaluated the anticancer effect and associated mechanism of SN38 in human colorectal carcinoma HCT 116 cells. As a result, SN38 could decrease the cell viability and induce DNA damage in a concentration-dependent manner. Furthermore, cell cycle arrest and intracellular nucleotide metabolism were perturbed due to DNA damage response, of which ATP, UTP, dATP, and TTP may be the critical metabolites during the whole process. Combined with the expression of deoxyribonucleoside triphosphates synthesis enzymes, our results demonstrated that the alteration and imbalance of deoxyribonucleoside triphosphates caused by SN38 was mainly due to the de novo nucleotide synthesis at 24 h, and subsequently the salvage pathways at 48 h. The unique features of SN38 suggested that it might be recommended as an effective supplementary drug with an anticancer effect. |
format | Online Article Text |
id | pubmed-8398164 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83981642021-08-29 Antitumor Mechanism of Hydroxycamptothecin via the Metabolic Perturbation of Ribonucleotide and Deoxyribonucleotide in Human Colorectal Carcinoma Cells Li, Yan Luo, Wendi Zhang, Huixia Wang, Caiyun Yu, Caiyuan Jiang, Zhihong Zhang, Wei Molecules Article Hydroxycamptothecin (SN38) is a natural plant extract isolated from Camptotheca acuminate. It has a broad spectrum of anticancer activity through inhibition of DNA topoisomerase I, which could affect DNA synthesis and lead to DNA damage. Thus, the action of SN38 against cancers could inevitably affect endogenous levels of ribonucleotide (RNs) and deoxyribonucleotide (dRNs) that play critical roles in many biological processes, especially in DNA synthesis and repair. However, the exact impact of SN38 on RNs and dRNs is yet to be fully elucidated. In this study, we evaluated the anticancer effect and associated mechanism of SN38 in human colorectal carcinoma HCT 116 cells. As a result, SN38 could decrease the cell viability and induce DNA damage in a concentration-dependent manner. Furthermore, cell cycle arrest and intracellular nucleotide metabolism were perturbed due to DNA damage response, of which ATP, UTP, dATP, and TTP may be the critical metabolites during the whole process. Combined with the expression of deoxyribonucleoside triphosphates synthesis enzymes, our results demonstrated that the alteration and imbalance of deoxyribonucleoside triphosphates caused by SN38 was mainly due to the de novo nucleotide synthesis at 24 h, and subsequently the salvage pathways at 48 h. The unique features of SN38 suggested that it might be recommended as an effective supplementary drug with an anticancer effect. MDPI 2021-08-13 /pmc/articles/PMC8398164/ /pubmed/34443490 http://dx.doi.org/10.3390/molecules26164902 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Li, Yan Luo, Wendi Zhang, Huixia Wang, Caiyun Yu, Caiyuan Jiang, Zhihong Zhang, Wei Antitumor Mechanism of Hydroxycamptothecin via the Metabolic Perturbation of Ribonucleotide and Deoxyribonucleotide in Human Colorectal Carcinoma Cells |
title | Antitumor Mechanism of Hydroxycamptothecin via the Metabolic Perturbation of Ribonucleotide and Deoxyribonucleotide in Human Colorectal Carcinoma Cells |
title_full | Antitumor Mechanism of Hydroxycamptothecin via the Metabolic Perturbation of Ribonucleotide and Deoxyribonucleotide in Human Colorectal Carcinoma Cells |
title_fullStr | Antitumor Mechanism of Hydroxycamptothecin via the Metabolic Perturbation of Ribonucleotide and Deoxyribonucleotide in Human Colorectal Carcinoma Cells |
title_full_unstemmed | Antitumor Mechanism of Hydroxycamptothecin via the Metabolic Perturbation of Ribonucleotide and Deoxyribonucleotide in Human Colorectal Carcinoma Cells |
title_short | Antitumor Mechanism of Hydroxycamptothecin via the Metabolic Perturbation of Ribonucleotide and Deoxyribonucleotide in Human Colorectal Carcinoma Cells |
title_sort | antitumor mechanism of hydroxycamptothecin via the metabolic perturbation of ribonucleotide and deoxyribonucleotide in human colorectal carcinoma cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398164/ https://www.ncbi.nlm.nih.gov/pubmed/34443490 http://dx.doi.org/10.3390/molecules26164902 |
work_keys_str_mv | AT liyan antitumormechanismofhydroxycamptothecinviathemetabolicperturbationofribonucleotideanddeoxyribonucleotideinhumancolorectalcarcinomacells AT luowendi antitumormechanismofhydroxycamptothecinviathemetabolicperturbationofribonucleotideanddeoxyribonucleotideinhumancolorectalcarcinomacells AT zhanghuixia antitumormechanismofhydroxycamptothecinviathemetabolicperturbationofribonucleotideanddeoxyribonucleotideinhumancolorectalcarcinomacells AT wangcaiyun antitumormechanismofhydroxycamptothecinviathemetabolicperturbationofribonucleotideanddeoxyribonucleotideinhumancolorectalcarcinomacells AT yucaiyuan antitumormechanismofhydroxycamptothecinviathemetabolicperturbationofribonucleotideanddeoxyribonucleotideinhumancolorectalcarcinomacells AT jiangzhihong antitumormechanismofhydroxycamptothecinviathemetabolicperturbationofribonucleotideanddeoxyribonucleotideinhumancolorectalcarcinomacells AT zhangwei antitumormechanismofhydroxycamptothecinviathemetabolicperturbationofribonucleotideanddeoxyribonucleotideinhumancolorectalcarcinomacells |